Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NovoCure Ltd | 252,290 | reported | 28 Jun 2024 | tx 336+3,198,256−2,555,484 |
| OptiNose, Inc. | 0 | reported | 21 May 2025 | tx 16+247,135−16,472 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2025 | OTHER | OptiNose, Inc. | 2,133 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 962 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 962 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 962 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 3,566 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 1,925 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 962 | — | deriv |
| 21 May 2025 | OTHER | OptiNose, Inc. | 5,000 | — | deriv |
| 28 Jun 2024 | GRANT_AWARD | NovoCure Ltd | 1,055 | 12.24 USD | |
| 06 Jun 2024 | GRANT_AWARD | OptiNose, Inc. | 75,000 | 0.00 USD | deriv |
| 05 Jun 2024 | EXERCISE | NovoCure Ltd | 124,373 | 22.82 USD | |
| 05 Jun 2024 | EXERCISE | NovoCure Ltd | 124,373 | 22.82 USD | deriv |
| 01 Mar 2024 | SALE | NovoCure Ltd | 2,107 | 16.03 USD | |
| 04 Mar 2024 | SALE | NovoCure Ltd | 1,217 | 16.01 USD | |
| 28 Feb 2024 | SALE | NovoCure Ltd | 2,303 | 16.14 USD | |
| 27 Feb 2024 | GRANT_AWARD | NovoCure Ltd | 47,034 | 16.30 USD | |
| 31 Dec 2023 | GRANT_AWARD | NovoCure Ltd | 3 | 12.69 USD | |
| 27 Feb 2024 | GRANT_AWARD | NovoCure Ltd | 71,920 | 16.30 USD | deriv |
| 01 Sept 2023 | SALE | NovoCure Ltd | 294 | 21.82 USD | |
| 30 Jun 2023 | GRANT_AWARD | NovoCure Ltd | 366 | 35.28 USD | |
| 08 Jun 2023 | GRANT_AWARD | OptiNose, Inc. | 53,500 | 0.00 USD | deriv |
| 03 Mar 2023 | SALE | NovoCure Ltd | 20,415 | 76.16 USD | |
| 03 Mar 2023 | SALE | NovoCure Ltd | 1,692 | 76.16 USD | |
| 03 Mar 2023 | SALE | NovoCure Ltd | 3,528 | 76.16 USD | |
| 03 Mar 2023 | GRANT_AWARD | NovoCure Ltd | 3,936 | 0.00 USD |